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The c o r r e l a t i o n o f f a s t i n g g l u c o s e L HbAlc was n o t s i g n i f i c a n t r = 0 . 1 .
E l e v a t e d HbAlc i n v i v o r e m a i n s unchanged a f t e r 24 h r s . o f g l u c o s e c o n c e n t r a t i o n s <150 mg/dl b u t s o r b i t o l c o n c e n t r a t i o n s r e f l e c t h o u r l y c h a n g e s i n g l u c o s e c o n c e n t r a t i o n . RBC s o r b i t o l d i r e c t l y q u a n t i t a t e s a m e d i a t o r o f c e l l u l a r p a t h o logy i n d i a b e t e s a s it r e f l e c t s t h e mean b l o o d g l u c o s e l e v e l s . RB( S o r b i t o l i s t h e r e f o r e t h e most u s e f u l i n d i c a t o r o f e f f e c t i v e m n n t HYPERTRIIODOTHYRONINEMIA WITH THYROGLOBULIN THERAPY.
Edgar Mori 1 l o and L y t t I. Gardner, Dept. o f Peds., SUNY, Upstate Med. C t r . . Svracuse. New York.
--Hypertriiodothyroninemia (hyper-T3) was noted i n 2 hypothyr o i d c h i l d r e n t r e a t e d w i t h desiccated t h y r o i d (Abbassi and Aldige, J. Ped. 90:298, 1977) . We have a l s o observed t h i s i n 6 h y p o t h y r o i d p a t i e n t s r e c e i v i n g t h y r o g l o b u l i n ( P r o l o i d r ) . T3 by RIA and T4 by RIA o r CPB were measured i n 2 boys and a g i r l wit1 g o i t r o u s hypothyroidism (ages 7, 16 and 12 y e a r s ) , i n a c r y p t ot h y r o i d boy (age 15), i n a woman w i t h c o n g e n i t a l a t h y r e o s i s (age 23) and i n a g i r l w i t h hypothyroidism secondary t o t h y r o i d i t i s . Therapy had been i n progress a t l e a s t 3 months, and i n 3 cases f o r as l o n g as 7 years when hyper-T3 was observed. Four p a t i e n t s showed above normal l e v e l s o f serum T3 when T4 values were below normal. A value o f T3 i n excess o f 400 ng/dl (beyond range o f h i g h e s t standard, w i t h N-97-217) was found i n t h e womal w i t h c o n g e n i t a l a t h y r e o s i s ; serum T4 was normal. C l i n i c a l e v a lu a t i o n revealed no f i n d i n g s a t t r i b u t a b l e t o excess o f t h y r o i d hormones except s l i g h t nervousness o r t r a n s i t o r y heat i n t o l e rance. I n 2 p a t i e n t s s u b s t i t u t i o n o f l e v o t h y r o x i n e f o r t h y r og l o b u l i n therapy has been associated w i t h a f a l l o f serum T3 values t o normal. I t has been e s t a b l i s h e d t h a t serum T3 l e v e l s i n c h i l d r e n a r e h i g h e r than i n a d u l t s ( F i s h e r e t a l . , JCEM 45:191, 1977) , b u t t h e hyper-T3 values we have observed a r e above t h i s range. I t i s as y e t unknown if t h e hyper-T3 o f these p a t i e n t s i s due t o T3 l o a d from t h e t h y r o g l o b u l i n medication o r i s an endogenous p e r i p h e r a l monodeiodination o f T4.
U n i v e r s i t y o f Texas M e d i c a l B r a n c h , Department of P e d i a t r i c s , G a l v e s t o n , Texas. The e t i o l o g y o f t h e g e n i t a l a n o m a l i e s i n two u n r e l a t e d t e e na g e r s w i t h male p s e u d o h e r m a p h r o d i t i s m and r e n a l d i s e a s e h a s been i n v e s t i g a t e d . P a t i e n t A , 15-5/12 y e a r o l d XY b l a c k , h a s s t a g e 5 p u b i c h a i r , p e r i n e a l h y p o s p a d i u s , 3 c c f i r m d e s c e n d e d r i g h t t e s t i s , undescended l e f t t e s t i s , 1 2 cm p h a l l u s w i t h c o r d a e , and f o c a l s e g m e n t a l g l o m e r u l o n e p h r i t i s . P a t i e n t B, 13-2/12 y e a r o l d XI w h i t e , showed s t a g e 2 p u b i c h a i r , lo h y p o s p a d i u s , 6 cm p h a l l u s , b i l a t e r a l l y undescended t e s t e s , l e f t r e n a l a g e n e s i s and r i g h t v e s i c o u r e t e r a l r e f l u x w i t h a s m a l l h y d r o n e p h r o t i c k i d n e y .
Also P a t i e n t B h a s a n a l a t r e s i a and v e r t e b r a l a n o m a l i e s . Although n e i t h e r h a s a u t e r u s o r f a l l o p i a n t u b e s , P a t i e n t A h a s a r u d i m e n t a r y v a g i n a . P a t i e n t A had e l e v a t e d g o n a d o t r o p i n s (FSH >160, LH=60 miulml) and h i s t e s t o s t e r o n e d i d n o t r i s e ( 9 9 5 + 7 3 8 n g l d l ) a f t e r 5 d a y s of HCG. P a t i e n t B ' s g o n a d o t r o p i n s (FSH=7.0, LH=5.0 miulml) were normal and t e s t o s t e r o n e r o s e w i t h HCG ( 3 9 6 3 915 n g l d l ) n i n u t e r o r a t h e r t h a n a n e n z y m a t i c d e f e c t i n s t e r o i d o g e n e s i s o r a d e f e c t i n androgen b i n d i n g .
-299 n g / d l . Dexamethasone ( 3 . 7 5 mg/m2 x 3d) f a i l e d t o s u p p r e s s v a t e d u r i n e 17-OHCS ( 1 0 . 1 mg124h) and f r e e c o r t i s o l (1026 ug/ 1 and plasma ACTH from 320 t o 90 pg/ml. I n r e s p o n s e t o TRF, TSH o s e t o 1 . 9 ~~U l m l , p r o l a c t i n r o s e t o 8 . 3 ng/ml and ACTH d i d n o t h a n g e . B r a i n CT s c a n and a n g i o g r a p h y d e m o n s t r a t e d a l a r g e subr o n t a l tumor which a p p e a r e d t o b e s e p a r a t e from t h e p i t u i t a r y o s s a . Craniotomy d e m o n s t r a t e d a n i n o p e r a b l e h i g h l y v a s c u l a r tumo x t e n d i n g i n t o t h e s e l l a . Biopsy of t h e main body of t h e tumor howed u n d i f f e r e n t i a t e d mesenchymal t i s s u e w i t h some g l a n d formai o n , w h i l e tumor s u p e r i o r t o t h e s e l l a h i s t o l o g i c a l l y r e s e m b l e d i t u i t a r y adenoma. Medium from c u l t u r e d c e l l s from t h e mesenchya 1 t i s s u e c o n t a i n e d ' n o m e a s u r a b l e ACTH w h i l e medium from t h e u l t u r e d adenomatous c e l l s c o n t a i n e d 111-140 pg ACTHlml. T h e r e wa o b i o a s s a y a b l e CRF a c t i v i t y i n t h e medium from any c u l t u r e d c e l l T o t a l a d r e n a l w e i g h t a t a u t o p s y was 1 5 gm. The b r a i n tumor was
I n t h e course o f s t u d i e s on somatomedin a c t i v i t y we have n o t e t h a t normal r a t serum r o u t i n e l y i n h i b i t e d 3~-t h y m i d i n e i n c o r p o ra t i o n by r a t o r p o r c i n e c a r t i l a g e w h i l e , a t t h e same time, i t s t i m u l a t e d s u l f a t e i n c o r p g r a t i o n . Human serum d i d n o t show t h i s s e l e c t i v e i n h i b i t i o n f o r H-thvmidine i n c o r~o r a t i o n i n t h e somatomedin bioassay fystem. w i t h -p o r c i n e c a r t i l a g e we found a -s e r u r dose response o f H-thymidine i n h i b i t i o n a t serum c o n c e n t r a t i o n s from 0.625% t o 40%. I n h i b i t o r y a c t i v i t y was s t a b l e t o repeated
f r e e z i n g and thawing, storage i n a p a r t i a l l y p u r i f i e d s t a t e a t 4' f o r two weeks, and h e a t i n g a t 90' f o r 30 min. a t pH 5.5. I n h i b it i o n occurred i n c a r t i l a g e o f f a s t e d , hypophysectmized o r cont r o l r a t s . With d i f f e r e n t du a t i o n s o f p r e -i n c u b a t i o n and/or i nc u b a t i o n r a t serum i n h i b i t e j 'H-thymidine uptake i n a l l samples, b u t human serum s t i m u l a t e d H-thymidine uptake over l o n g p e r i o d s . Untreated serum r e t a i n e d i t s i n h i b i t o r y a c t i v i t y a f t e r prolonged d i a l y s i s ; a d d i t i o n o f anmonium s u l f a t e a t 10% s a t u r a t i o n o r g r e a t e r and d i a l y s i s r e s u l t e d i n l o s s o f a l l serum a c t i v i t y . S i g -' l i f i c a n t p u r i f i c a t i o n o f t h e f a c t o r was achieved by g e l f i l t r at i o n on Bio-Gel P-200. The a c t i v e f r a c t i o n had an a b s o r p t i o n maximum a t 260nm c o n s i s t e n t w i t h t h e presence o f n u c l e i c a c i d ; t h e r e Mere no a b s o r p t i o n peaks a t 230nm o r 280nm. There was no p r o t e i n i e t e c t a b l e by t h e method o f Lowry, g c. and t h e r e was no DNA (JCEM 43:799, 1977) . The 11 ketoreductase d e f i c i e n c y was demonstrated by a markedly e l e v a t e d r a t i o o f u r i n a r y THF/THE (6-10) i n t h e r e s t i n g s t a t e d u r i n g ACTH and hydro c o r t i s o n e treatment. I n normal c h i l d r e n t h e THF/THE r a t i o i s u s u a l l y l e s s than 1. The d e f i c i e n c y was f u r t h e r proven by demons t r a t i n g an i n a b i l i t y t o form t r i t i a t e d water a f t e r i n f u s i o n of 1 1~x 3~ c o r t i s o l . I n normal s u b j e c t s and i n t h e u n a f f e c t e d mother o f a p a t i e n t , 65-80% o f 1 1~~3~ c o r t i s o l appeared as tri t i a t e d water.
Speculation: I n these p a t i e n t s t h e 11 ketoreductase d e f i c i e n c produces an impairment o f t h e m e t a b o l i s m o f c o r t i s o l t o c o r t i s o n e , r e s u l t i n g i n a prolonged c o r t i s o l h a l f -l i f e , suppression o f ACTH and normal serum c o r t i s o l c o n c e n t r a t i o n . The enzyme d e f e c t prot e c t s t h e p a t i e n t from adrenal i n s u f f i c i e n c y d e s p i t e low c o r t i s o s e c r e t i o n and may c o n t r i b u t e t o hypertension and hyporeninemia 'because o f f o r m a t i o n o f excess DHF which has m i n e r a l o c o r t i c o i d f c t i v i t y .
